Skip to main content

Latest News

December 28, 2020
European Medicines Agency Validates Bristol Myers Squibb’s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis
December 23, 2020
Bristol Myers Squibb Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme
December 21, 2020
Bristol Myers Squibb to Announce Results for Fourth Quarter 2020 on February 4, 2021

Latest Events

Event year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
November 18, 2020 09:15 AM ET
Wolfe Research Healthcare Conference
Webcast (opens in new window)
November 5, 2020 08:30 AM EST
Bristol Myers Squibb 2020 Third Quarter Results Conference Call
Webcast (opens in new window)
  • Press Release
  • Press Release (PDF) (opens in new window) (PDF949 KB)
  • Quarterly Package of Financial Information (XLS) (opens in new window) (Excel4.14 MB)
  • View this presentation (opens in new window) (PDF1.10 MB)
October 12, 2020 08:00 AM ET
Bristol Myers Squibb at UEGW 2020
Webcast (opens in new window)
  • Event Slides (opens in new window) (PDF720 KB)